Page last updated: 2024-11-03

pyrilamine and Cancer of Endocrine Gland

pyrilamine has been researched along with Cancer of Endocrine Gland in 1 studies

Pyrilamine: A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
mepyramine : An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"Pyrilamine treatment did not reduce survival."2.39Chronic feeding study of pyrilamine in Fischer 344 rats. ( Allaben, W; Allen, R; Cronin, GM; Dahlgren, R; Greenman, DL, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenman, DL1
Cronin, GM1
Dahlgren, R1
Allen, R1
Allaben, W1

Reviews

1 review available for pyrilamine and Cancer of Endocrine Gland

ArticleYear
Chronic feeding study of pyrilamine in Fischer 344 rats.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 25, Issue:1

    Topics: Adrenal Medulla; Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Eating; Endocrine Gland N

1995